| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| Retroviral vector-transduced autologous T cells to express anti-ALPP CARs (TCRCure Biopharma Corporation) | Phase 2 Clinical | Xinqiao Hospital, Army Medical University | Ovarian Neoplasms; Endometrial Neoplasms | Details |